Sort
51,593 grants matching “hepatitis”
We are here now - a multi-level, multi-component sexual and reproductive health intervention for American Indian youth
$624,397Elizabeth Lynne Rink · Montana State University - Bozeman · R01 · FY2021 · MD
HIV Risk and Neighborhood Networks of New IDUs
$624,291National Development &Res Institutes · R01 · FY2003 · DA
Analysis of immunity, viral adaptation and pathogenesis in a new mouse model of HCV-related rodent hepacivirus infection
$624,270Charles M. Rice · Rockefeller University · R01 · FY2019 · AI
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection
$624,242Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2017 · AG
Understanding Survival of Human Bone Marrow Long-Lived Plasma Cells
$624,142Frances Eun-Hyung Lee · Emory University · R01 · FY2019 · AI
In Vivo And In Vitro Studies Of Hepatitis E Virus
$624,136Suzanne U Emerson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Soluble epoxide hydrolase-regulated lipid signaling in Alzheimerâs disease
$624,039Izumi Maezawa · University Of California At Davis · R01 · FY2025 · AG
Adiponectin in Cardiovascular Biology and Pathology
$624,029Harvey F Lodish · Massachusetts Institute Of Technology · P01 · FY2009 · HL
Expression, Regulation and Function of the SULT1C Carcinogen-Activating Enzymes
$623,997Melissa A Runge-Morris · Wayne State University · R01 · FY2023 · ES
Improving Outcome in Patients with Advanced Intrahepatic Cholangiocarcinoma: A Randomized Phase II Study of Gemcitabine and Oxaliplatin With or Without Regional Floxuridine (FUDR)
$623,923William Robert Jarnagin · Sloan-Kettering Inst Can Research · U01 · FY2024 · CA
Continuum of Care for Drug-Involved Offenders
$623,843Peter D. Friedmann · Rhode Island Hospital · U01 · FY2010 · DA
RMI HIV/STD, TB, VIRAL HEPATITIS PROGRAMS
$623,839Julia M Alfred · Rep/Marshall Islands- Ministry Of Health · U52 · FY2015 · PS
Reverse-engineering precision liver cancer chemoprevention
$623,745Yujin Hoshida · Ut Southwestern Medical Center · R01 · FY2020 · CA
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning
$623,700Adam R. Abate · University Of California, San Francisco · R01 · FY2023 · AI
Novel therapies that target mitochondrial dysfunction for treatment of a1-antitrypsin deficiency liver disease
$623,637David A Rudnick · Washington University · R01 · FY2023 · DK
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine
$623,635Sebastian Seiguer · Emocha Mobile Health, Inc. · R44 · FY2019 · DA
MOLECULAR BEACONS FOR RETROVIRAL DIAGNOSTICS
$623,609Public Health Research Institute · R01 · FY2004 · EB
Role of IgG Fc Glycan Composition in Vaccination
$623,583Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2017 · AI
Native Transformations Opiate Project
$623,556Stacy M. Rasmus · Northwest Indian College · S06 · FY2019 · GM
Phenylbutyrate therapy for maple syrup urine disease
$623,541Brendan Hl Lee · Baylor College Of Medicine · R01 · FY2014 · DK
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak Investigation
$623,509Todd M Allen · Massachusetts General Hospital · U24 · FY2017 · DA
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$623,455Douglas K Owens · Stanford University · R01 · FY2016 · DA
Vaccination strategies to overcome immune deficiencies in neonates
$623,271Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2012 · AI
Clinical protocols for the treatment of gastrointestinal cancer
$623,247Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
A Network &Dyad HIV Prevention Intervention for IDUs
$623,235Johns Hopkins University · R01 · FY2004 · DA